“
“The dependence of shear strength of epoxidized natural rubber (ENR)-based adhesives on molecular

weight of the rubber is studied using coumarone-indene resin, gum rosin, and petro resin as tackifiers. The adhesive was coated on polyethylene terephthalate (PET) film substrate using a SHEEN hand coater at various coating thickness. The shear strength of adhesives was determined by a Texture Analyzer. Results show a maximum at 6.63 x 10(4) and 4.14 x Pinometostat 10(4) for ENR 25 and ENR 50, respectively, after which the shear strength decreases with further increases in molecular weight for all the coating thickness. This observation is attributed to varying degree of cohesiveness which culminates at the respective optimum molecular weight of ENR. (C) 2009 Wiley Periodicals, Inc. J Appl Polym Sci 114: 3976-3979, 2009″
“Forty-two consecutive pediatric patients with high-risk leukemia who received cord blood (CB) transplantation at the authors’ institution from January 1996 and December 2007 were included in this study. Age ranged from 6 months to 18 years and body weight from

7 to 73 kg. Twenty-nine patients had ALL and 13 AML. Twenty-seven out of 42 patients were transplanted in advanced phase of disease (beyond 2nd CR). For 13 patients the CB transplantation was their second transplant. The median follow-up for survivors was 60 months (range, 6-120 months). The probability of myeloid engraftment was 95 5% and the median time to neutrophil 500/L was 20 days (range, 12-54). The median time PP2 in vitro to platelet engraftment was 60 days (range, 37-200). The probability of relapse was 33 9%. The nonrelapse

mortality at day +100 after transplantation was 30 7%. The probability of disease-free survival was 34 7%. The CD34+ cell dose had a significant impact on DFS (HR, 3.28; 95% CI: 1.49-7.23; p = .003). The results from a long-term follow-up study suggest that cord blood transplantation should be performed in the early phase of disease whenever possible. The cord blood unit for transplantation in pediatric patients with hematological malignancies should be chosen based on cell dose, especially a CD34+ cell dose.”
“The objective of this study was to determine the physicochemical and nanostructural properties of the alkali pre-treated gelatin from Duvelisib 3 different body parts (skin, muscle, and bone) of cornet fish (Fistularia petimba). The maximum yield of protein and viscosity was obtained in bone than other parts and Fourier transform infrared (FTIR) spectroscopy was carried out to characterize the extracted gelatin. Prior to extraction, the proximate composition was investigated clearly and the percentage of protein (15.50-29%), ash (4.32-6.50%), moisture (71.85-79.20%), and lipid (0.36-1.38%) content were estimated. Morphology of alkaline gelatin extracted from skin, muscle, and bone were studied using atomic force microscopy (AFM). The AFM images represented the scanning was done at 1.